Dr. Michael Cummings, a renowned psychopharmacologist, joins the conversation to unpack the tricky link between psychiatric medications and weight gain. They delve into how antipsychotics can disrupt metabolism and appetite regulation, revealing the science behind this issue. With insights on GLP-1 agonists and effective lifestyle changes, Cummings emphasizes practical strategies for managing medication-induced weight gain. They also discuss the importance of individualized approaches to treatment, making the case for regular monitoring and patient motivation.

Medical doctors Michael Cummings and Melissa Pereau, along with aspiring psychiatrist Chantel Fletcher, dive deep into Obsessive Compulsive Disorder. They explore the historical roots of OCD and its diagnostic evolution, discuss treatment complexities including dopamine blocking agents, and emphasize the vital role of the Yale-Brown Obsessive Compulsive Scale. The trio also clarifies the distinctions between OCD and OCPD and uncovers the interconnectedness of OCD with eating disorders, stressing the importance of tailored therapeutic approaches.

Dr. Michael Cummings, an expert in Psychiatry and Schizophrenia, answers listener questions on topics like treating Schizophrenia with long-acting injectables, the effectiveness of clozapine in treatment-resistant cases, and the debate on psychiatric medications' limitations. He also discusses managing breakthrough psychosis, treatment algorithms for depression, and the FDA-approved drug Karaprazine's efficacy in depression treatment.

Join Stephen Stahl, a prominent psychopharmacology expert, and David Goodman, an ADHD specialist, as they discuss the complexities of diagnosing ADHD in women. They highlight societal biases and the role of hormonal changes in managing the condition. Michael Cummings shares insights on navigating treatment-resistant psychosis, emphasizing the use of clozapine for improved outcomes. James Knoll delves into antisocial personality disorder, exploring its origins and gender differences, while addressing the societal perceptions surrounding these disorders.

Dr. Michael Cummings discusses a new study challenging the idea of depression as a chemical imbalance. The podcast explores the complexities of depression beyond serotonin levels, the effects of antidepressants and ketamine on dendrites, the link between depression and accelerated aging, health issues related to depression, and the impact of psychotherapy and medication. It also covers the role of chronic stress on the brain and how individuals can overcome depression.